Unlock your academic potential and expand your network by joining us!

Dr. José Pérez de la Lastra

Information

Dr. José Manuel Pérez de la Lastra received his Bachelor's degree in Chemistry (BioChem and Mol Biol) from the Autonomous University of Madrid in 1992 and received his Master’s degree in Biotechnology in 1993. He received his PhD from the University of Cordoba in 1996. Dr. Pérez de la Lastra is a scientist at the Institute of Natural Products and Agrobiology. His research is based on the development of biotechnological applications from the immune system of different organisms. In particular, his work focuses on the study of the innate immune defense of animals that live in pathogenic environments to which they have to be adapted in order to resist the very high microbial load. The aim is to provide innovative solutions to current antimicrobial resistance challenges while reducing the environmental impact of conventional antimicrobials. Dr. Pérez de la Lastra also has extensive experience in the use of peptides to study antigenic epitopes in vaccine development and in the discovery of antimicrobial peptides. Dr. Pérez de la Lastra is the author of more than 100 SCI articles (H index = 31) and several book chapters.

Research Keywords & Expertise

Antibodies
Biotechnology
Cloning
Immunity
Molecular

Fingerprints

Antibodies
Immunity
Molecular
Peptides
antimicrobial
Cloning
Epitopes
Biotechnology
Nanotechnology
natural antimicrobials

Short Biography

Dr. José Manuel Pérez de la Lastra received his Bachelor's degree in Chemistry (BioChem and Mol Biol) from the Autonomous University of Madrid in 1992 and received his Master’s degree in Biotechnology in 1993. He received his PhD from the University of Cordoba in 1996. Dr. Pérez de la Lastra is a scientist at the Institute of Natural Products and Agrobiology. His research is based on the development of biotechnological applications from the immune system of different organisms. In particular, his work focuses on the study of the innate immune defense of animals that live in pathogenic environments to which they have to be adapted in order to resist the very high microbial load. The aim is to provide innovative solutions to current antimicrobial resistance challenges while reducing the environmental impact of conventional antimicrobials. Dr. Pérez de la Lastra also has extensive experience in the use of peptides to study antigenic epitopes in vaccine development and in the discovery of antimicrobial peptides. Dr. Pérez de la Lastra is the author of more than 100 SCI articles (H index = 31) and several book chapters.